Concepedia

Alejandra Trejo

AT

3

Publications

232

Citations

3

H-Index

2003

Active since

Affiliations

Roche (United States)(Current)

Alejandra Trejo is an author at Roche (United States) specializing in drug discovery, medicinal chemistry, and natural sciences.

Top concepts

Publications per year

2003–2011

3

Publications

3

Design and Synthesis of 4-Azaindoles as Inhibitors of p38 MAP Kinase

Alejandra Trejo, Humberto Arzeno, Michelle F. Browner et al. · Journal of Medicinal Chemistry · 2003 · 94 citations · Full text

, , +17

Discovery of 6-(2,4-Difluorophenoxy)-2-[3-hydroxy-1-(2-hydroxyethyl)propylamino]-8-methyl-8<i>H</i>-pyrido[2,3-<i>d</i>]pyrimidin-7-one (Pamapimod) and 6-(2,4-Difluorophenoxy)-8-methyl-2-(tetrahydro-2<i>H</i>-pyran-4-ylamino)pyrido[2,3-<i>d</i>]pyrimidin-7(8<i>H</i>)-one (R1487) as Orally Bioavailable and Highly Selective Inhibitors of p38α Mitogen-Activated Protein Kinase

David Goldstein, Michael Soth, Tobias Gabriel et al. · Journal of Medicinal Chemistry · 2011 · 74 citations · Full text

, , +21

Discovery of <i>S</i>-[5-Amino-1-(4-fluorophenyl)-1<i>H</i>-pyrazol-4-yl]-[3-(2,3-dihydroxypropoxy)phenyl]methanone (RO3201195), an Orally Bioavailable and Highly Selective Inhibitor of p38 Map Kinase

David Goldstein, Tom Alfredson, J. A. Bertrand et al. · Journal of Medicinal Chemistry · 2006 · 64 citations · Full text

Rows per page

1–3 of 3